Cite Filings / MLTX / 0001213900-20-032599
Feed Companies Filings Check
Sign in
424B4

Prospectus

MoonLake Immunotherapeutics · Filed 2020-10-21 · Acc 0001213900-20-032599

Documents 1

  • 424B4 Prospectus , f424b41020_helixacqcorp.htm

Around this filing

  • 2020-10-22 4 CEO and Chairman bought 430,000 shares at $10.00 ($4,300,000)
  • 2020-10-22 4 Director bought 430,000 shares at $10.00 ($4,300,000)
  • 2020-10-22 8-K Material agreement · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Other events
  • 2020-10-21 424B4 Prospectus
  • 2020-10-20 CERT Certification
  • 2020-10-19 EFFECT Notice of Effectiveness
  • 2020-10-19 3 Initial Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading f424b41020_helixacqcorp.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…